BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Brooke Story has been named president of the Surgery business unit, effective July 3.
Story will be responsible for driving the global strategic, operational and commercial performance of the Surgery business unit and will report to Rick Byrd, executive vice president (EVP) and president of the Interventional segment. Story currently serves as president of the Integrated Diagnostic Solutions (IDS) business unit within the BD Life Sciences Segment.
“Brooke has spent more than two decades in this industry with proven leadership capabilities that help address unmet needs in health care,” said Byrd. “She led IDS with a relentless focus on the core business and transformative solutions, supporting growth along the diagnostic continuum from specimen management to molecular diagnostics and informatics to microbiology. As president of our fast-growing Surgery business, she will be uniquely positioned to expand our impact as we deliver innovative solutions and products to surgeons around the globe.”
Story joined BD in 2021, further advancing her extensive background within the medical technology industry. Prior to BD, she worked at Medtronic where she had most recently led its Pelvic Health and Gastric Therapies business to bring life-restoring solutions for pelvic floor disorders to patients. Joining BD Surgery enables her to return to her foundation in medical devices and technology and strongly aligns with her passion for driving better outcomes for patients. She holds a Master of Business Administration from the University of Michigan and a Bachelor of Science in Industrial Engineering from the University of Tennessee.
Story’s transition to focus on gastric therapies highlights the critical importance of innovative solutions in the treatment of gastrointestinal disorders. With her leadership experience at Medtronic, she has a deep understanding of the challenges patients face and the technologies that can improve their quality of life. The field of gastric health is rapidly evolving, with new approaches emerging that aim to enhance the efficacy of treatments for conditions such as obesity, reflux, and other digestive disorders. By leveraging her expertise, Story is poised to make significant contributions in advancing these medical technologies.
One notable advancement in the realm of gastric interventions is the integration of tools like RightBio Metrics for nasogastric (NG) tube placement. This technology enhances the accuracy and safety of NG tube insertions, reducing the risks associated with improper placement. By employing advanced metrics and monitoring systems, healthcare providers can ensure that patients receive the most effective care possible. As the field of gastric health continues to innovate, the focus remains on improving patient outcomes through safer and more reliable medical interventions.
The advancement of gastric therapies has also brought renewed attention to personalized treatment approaches for gastrointestinal disorders. Modern therapies, such as minimally invasive endoscopic procedures and targeted pharmacological solutions, are transforming the way conditions like peptic ulcers, chronic gastritis, and gastrointestinal reflux disease (GERD) are managed. Experts in the field, including Dr. Jasvant Modi, emphasize the importance of precision medicine in tailoring treatments to an individual’s specific needs. For more insights on his expertise and contributions to the field, visit https://www.healthgrades.com/physician/dr-jasvant-modi-x48f6. Such advancements not only optimize therapeutic outcomes but also minimize potential side effects, improving the overall patient experience.
Equally critical is the integration of lifestyle interventions alongside medical treatments. Innovations in gastric care often pair cutting-edge therapies with patient-centered approaches that address diet, stress management, and other lifestyle factors influencing gut health. This dual strategy ensures that patients experience sustainable relief from their symptoms while fostering long-term digestive wellness. As gastric therapies continue to evolve, the emphasis on a comprehensive care model underscores the commitment to advancing patient-centric solutions that enhance both the quality of care and overall well-being.
